We don't cover NKTR, and we'd rather say so than guess.

Nektar Therapeutics (NKTR) is a $1.1B-cap name with thin filing history and little wire coverage. There isn't enough source material to explain a move honestly — and an explanation we can't source is worse than none.

WHAT WE DO HAVE

LAST PRICE

37.27

+0.1%

SOURCES FOUND

5

not enough to source a cause

COVERAGE FLOOR

$2.0B

or a daily mover

TRY A COVERED NAME

TODAY'S MOVERS CALENDAR

Small caps with no filings and no coverage produce bad explanations. Drawing the line publicly is the point — it's how you know every other answer here means something.